From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges

Mesenchymal stromal cells (MSCs) are an attractive option for cell therapy for type 1 diabetes mellitus (DM). These cells can be obtained from many sources, but bone marrow and adipose tissue are the most studied. MSCs have distinct advantages since they are nonteratogenic, nonimmunogenic and have i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghoneim, Mohamed A., Refaie, Ayman F., Elbassiouny, Batoul L., Gabr, Mahmoud M., Zakaria, Mahmoud M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667138/
https://www.ncbi.nlm.nih.gov/pubmed/32880857
http://dx.doi.org/10.1007/s12015-020-10036-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667138/
https://www.ncbi.nlm.nih.gov/pubmed/32880857
http://dx.doi.org/10.1007/s12015-020-10036-3

Ejemplares similares